CXCL13 and cancer: Notably, genes upregulated in CXCL13+ exhausted T cells (CXCL13+ Tex) were enriched in responder-associated pathways such as PD-L1 expression and PD-1 checkpoint pathway in cancer and TCR signaling pathway for CD8+ T cell subtypes (Figure 3B).